Addressing the challenges of polygenic scores in human genetic research.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
01 12 2022
Historique:
entrez: 2 12 2022
pubmed: 3 12 2022
medline: 7 12 2022
Statut: ppublish

Résumé

The genotyping of millions of human samples has made it possible to evaluate variants across the human genome for their possible association with risks for numerous diseases and other traits by using genome-wide association studies (GWASs). The associations between phenotype and genotype found in GWASs make possible the construction of polygenic scores (PGSs), which aim to predict a trait or disease outcome in an individual on the basis of their genotype (in the disease case, the term polygenic risk score [PRS] is often used). PGSs have shown promise for studying the biology of complex traits and as a tool for evaluating individual disease risks in clinical settings. Although the quantity and quality of data to compute PGSs are increasing, challenges remain in the technical aspects of developing PGSs and in the ethical and social issues that might arise from their use. This ASHG Guidance emphasizes three major themes for researchers working with or interested in the application of PGSs in their own research: (1) developing diverse research cohorts; (2) fostering robustness in the development, application, and interpretation of PGSs; and (3) improving the communication of PGS results and their implications to broad audiences.

Identifiants

pubmed: 36459976
pii: S0002-9297(22)00460-8
doi: 10.1016/j.ajhg.2022.10.012
pmc: PMC9808501
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2095-2100

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Références

Nat Commun. 2019 Jan 18;10(1):333
pubmed: 30659178
N Engl J Med. 2015 Jan 29;372(5):397-9
pubmed: 25629736
Nat Genet. 2019 Apr;51(4):584-591
pubmed: 30926966
Public Health Genomics. 2012;15(1):11-21
pubmed: 21720148
Annu Rev Biomed Data Sci. 2022 Aug 10;5:321-339
pubmed: 35576557
Nat Genet. 2022 May;54(5):573-580
pubmed: 35513724
Nat Protoc. 2014 May;9(5):1192-212
pubmed: 24762786
Nat Genet. 2021 Apr;53(4):420-425
pubmed: 33692568
PLoS Biol. 2013 Sep;11(9):e1001661
pubmed: 24068893
Nature. 2011 Jul 13;475(7355):163-5
pubmed: 21753830
Genome Res. 2021 Apr;31(4):529-537
pubmed: 33536225
Elife. 2019 Mar 21;8:
pubmed: 30895923
Sci Rep. 2016 Oct 04;6:34386
pubmed: 27698363
Hum Genet. 2020 Jan;139(1):23-41
pubmed: 31030318
Sci Rep. 2021 May 4;11(1):9457
pubmed: 33947934
PLoS Biol. 2021 Jan 25;19(1):e3001072
pubmed: 33493148
PLoS Med. 2018 Mar 30;15(3):e1002546
pubmed: 29601582
BMC Med Genomics. 2021 Oct 1;14(1):238
pubmed: 34598685
Evol Med Public Health. 2018 Dec 27;2019(1):26-34
pubmed: 30838127
Sociol Sci. 2020 Sep;7:465-486
pubmed: 36091972
Am J Hum Genet. 2022 Jul 7;109(7):1286-1297
pubmed: 35716666
Am J Hum Genet. 2022 Jan 6;109(1):12-23
pubmed: 34995502
Genetics. 2018 Apr;208(4):1351-1355
pubmed: 29618592
Nature. 2021 Oct;598(7879):17-18
pubmed: 34580484
Science. 2019 Sep 27;365(6460):1396-1400
pubmed: 31604265
JAMA Oncol. 2016 Oct 01;2(10):1295-1302
pubmed: 27228256
PLoS Genet. 2014 Aug 07;10(8):e1004412
pubmed: 25102153
Nature. 2021 Mar;591(7849):211-219
pubmed: 33692554
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Am J Hum Genet. 2022 Sep 1;109(9):1563-1571
pubmed: 36055208
Nature. 2019 Oct;574(7780):618-620
pubmed: 31664197
Nat Commun. 2018 Mar 6;9(1):827
pubmed: 29511166
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7996-8000
pubmed: 24843128
Trends Genet. 2009 Nov;25(11):489-94
pubmed: 19836853
Am J Hum Genet. 2020 Jan 2;106(1):71-91
pubmed: 31901249
Annu Rev Genomics Hum Genet. 2013;14:491-513
pubmed: 24003856
Eur J Hum Genet. 2022 May;30(5):493-495
pubmed: 34916614
Nat Genet. 2012 Feb 05;44(3):243-6
pubmed: 22306651
N Engl J Med. 2021 Jul 1;385(1):78-86
pubmed: 34192436
Nat Genet. 2022 Apr;54(4):450-458
pubmed: 35393596
Am J Hum Genet. 2020 Sep 3;107(3):379-380
pubmed: 32888506
Philos Trans R Soc Lond B Biol Sci. 2022 Jun 6;377(1852):20200416
pubmed: 35430887
Elife. 2020 Jan 30;9:
pubmed: 31999256
Nature. 2021 Sep;597(7875):175-177
pubmed: 34489576
Med Decis Making. 2021 Apr;41(3):261-274
pubmed: 33655791
Elife. 2020 Dec 22;9:
pubmed: 33350384
Trends Genet. 2021 Nov;37(11):995-1011
pubmed: 34243982
Eur J Hum Genet. 2022 Jan;30(1):81-87
pubmed: 34276054
Am J Med Genet B Neuropsychiatr Genet. 2019 Dec;180(8):543-554
pubmed: 31124312
Eur J Hum Genet. 2018 Jul;26(7):984-995
pubmed: 29703952
Elife. 2019 Mar 21;8:
pubmed: 30895925
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Genome Med. 2020 Nov 23;12(1):100
pubmed: 33225976
Nature. 2016 Oct 12;538(7624):161-164
pubmed: 27734877
Hum Genet. 2022 May;141(5):1099-1107
pubmed: 35412078
Nat Commun. 2021 Feb 17;12(1):1098
pubmed: 33597505
Genet Med. 2021 May;23(5):942-949
pubmed: 33531665
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34131076
Fam Cancer. 2019 Jan;18(1):137-146
pubmed: 29846879
Annu Rev Psychol. 2021 Jan 4;72:37-60
pubmed: 32898465
Genetics. 2019 Apr;211(4):1131-1141
pubmed: 30967442
Circ Genom Precis Med. 2021 Aug;14(4):e000084
pubmed: 34304578
Nat Protoc. 2020 Sep;15(9):2759-2772
pubmed: 32709988
Elife. 2020 Nov 17;9:
pubmed: 33200985
Nat Genet. 2020 Dec;52(12):1346-1354
pubmed: 33257898
Nat Med. 2021 Nov;27(11):1876-1884
pubmed: 34782789
J Genet Couns. 2008 Feb;17(1):30-63
pubmed: 17968638
Nat Genet. 2021 Sep;53(9):1272-1274
pubmed: 34493865

Auteurs

John Novembre (J)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Department of Human Genetics, University of Chicago, Chicago, IL, USA; Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA. Electronic address: jnovembre@uchicago.edu.

Catherine Stein (C)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. Electronic address: cmj7@case.edu.

Samira Asgari (S)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Claudia Gonzaga-Jauregui (C)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; International Laboratory for Human Genome Research, Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Juriquilla, Querétaro, México.

Andrew Landstrom (A)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Department of Pediatrics, Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.

Amy Lemke (A)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Norton Children's Research Institute, affiliated with the University of Louisville School of Medicine, Louisville, KY, USA.

Jun Li (J)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.

Chloe Mighton (C)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Genomics Health Services Research Program, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Matthew Taylor (M)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Adult Medical Genetics Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Sarah Tishkoff (S)

Professional Practice and Social Implications Committee Polygenic Scores Guidance Writing Group, American Society of Human Genetics, Rockville MD, USA; Department of Genetics, Center for Global Genomics and Health Equity, University of Pennsylvania, Philadelphia, PA, USA; Department of Biology, Center for Global Genomics and Health Equity, University of Pennsylvania, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH